List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 953 studies with search of: India
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Enrolling by invitation A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (ucb 34714)
2 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
3 Recruiting Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: peg-interferon
4 Active, not recruiting The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: Humalog Low Mix
5 Completed Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexol Extended Release;   Drug: Pramipexol Immediate Release;   Drug: Placebo
6 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
7 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
8 Completed Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Fulvestrant
9 Active, not recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
10 Completed Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Condition: Schizophrenia
Interventions: Drug: iloperidone;   Drug: active comparator;   Drug: placebo
11 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
12 Recruiting Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Tenofovir;   Drug: Adefovir;   Drug: Lamivudine
13 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
14 Recruiting Study of Non-Small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-Based Treatment
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Pralatrexate Injection
15 Recruiting FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Intervention: Drug: Oral treprostinil (UT-15C) Sustained Release Tablets
16 Recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
17 Terminated Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
18 Active, not recruiting Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: pemetrexed;   Drug: Placebo
19 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
20 Recruiting PK/PD, Long-Term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder
Condition: Bladder, Neurogenic
Intervention: Drug: tamsulosin hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services